Tag Archive: fina

Dec 07

Biotech Financing: Those That Adapt to Change Will Survive

In the October issue of Biotechnology Focus, Cato Research’s very own Chief Financial Officer and Principal of Cato BioVentures, Daniel Pharand, discusses the recent shift and latest trends in financing within the biotechnology industry.  “There have been a number of trends in the biotech funding world since its last bubble and bust in the early …

Continue reading »